Override of the Osteoclast Defect in Osteopontin-Deficient Mice by Metastatic Tumor Growth in the Bone

American Journal of Pathology - United States
doi 10.2353/ajpath.2006.050480
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Osteopontin-Deficient Mice Are Resistant to Ovariectomy-Induced Bone Resorption

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Accelerated Tumor Growth in Mice Deficient in DNAM-1 Receptor

Journal of Experimental Medicine
MedicineAllergyImmunology
2008English

Shape Analysis of the Basioccipital Bone in Pax7-Deficient Mice

Scientific Reports
Multidisciplinary
2017English

Alteration of Tumor Spectrum by ISGylation in P53-Deficient Mice

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Increased Bone Formation in Osteocalcin-Deficient Mice

Nature
Multidisciplinary
1996English

MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation

Journal of Clinical Medicine
2015English

Remodeling Capacity of Femoral Bone Defect by POP-CHA Bone Substitute: A Study in Rats’ Osteoclast (First Series of POP-based Bone Graft Improvement)

The Indonesian Journal of Dental Research
2015English

Angiotensin II–accelerated Atherosclerosis and Aneurysm Formation Is Attenuated in Osteopontin-Deficient Mice

Journal of Clinical Investigation
Medicine
2003English

Osteopontin but Not Osteonectin Favors the Metastatic Growth of Pancreatic Cancer Cell Lines

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy